These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12136371)

  • 21. Hemodialysis of doxepin and desmethyldoxepin in uremic patients.
    Faulkner RD; Senekjian HO; Lee CS
    Artif Organs; 1984 May; 8(2):151-5. PubMed ID: 6732542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of doxepin and its major metabolite desmethyldoxepin in hair following drug therapy.
    Negrusz A; Moore CM; Perry JL
    J Anal Toxicol; 1998 Oct; 22(6):531-6. PubMed ID: 9788530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A fatal doxepin poisoning associated with a defective CYP2D6 genotype.
    Koski A; Ojanperä I; Sistonen J; Vuori E; Sajantila A
    Am J Forensic Med Pathol; 2007 Sep; 28(3):259-61. PubMed ID: 17721180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse effects in a newborn infant breast-fed by a mother treated with doxepin.
    Frey OR; Scheidt P; von Brenndorff AI
    Ann Pharmacother; 1999 Jun; 33(6):690-3. PubMed ID: 10410181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma levels of the cis- and trans-isomers of doxepin and desmethyldoxepin after administration of doxepin to patients.
    Bogaert MG; Rosseel MT; Deberdt R; Vranckx C
    Arzneimittelforschung; 1981; 31(1):113-5. PubMed ID: 7194087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doxepin plasma concentrations: is there really a therapeutic range?
    Leucht S; Steimer W; Kreuz S; Abraham D; Orsulak PJ; Kissling W
    J Clin Psychopharmacol; 2001 Aug; 21(4):432-9. PubMed ID: 11476128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus.
    Staatz CE; Tett SE
    Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting.
    Nakade S; Ohno T; Kitagawa J; Hashimoto Y; Katayama M; Awata H; Kodama Y; Miyata Y
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):75-83. PubMed ID: 18317761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The isomeric metabolites of doxepin in equine serum and urine.
    Hagedorn HW; Meiser H; Zankl H; Schulz R
    J Pharm Biomed Anal; 2002 Jun; 29(1-2):317-23. PubMed ID: 12062692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma and erythrocyte levels of tricyclic antidepressants in depressed patients.
    Linnoila M; Dorrity F; Jobson K
    Am J Psychiatry; 1978 May; 135(5):557-61. PubMed ID: 347952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of single and repeated doses of activated charcoal on the pharmacokinetics of doxepin.
    Scheinin M; Virtanen R; Iisalo E
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):38-42. PubMed ID: 3988390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative GLC determination of cis- and trans-isomers of doxepin and desmethyldoxepin.
    Rosseel MT; Bogaert MG; Claeys M
    J Pharm Sci; 1978 Jun; 67(6):802-5. PubMed ID: 660461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma levels of tricyclic antidepressants and clinical efficacy: review of the literature -- part II.
    Risch SC; Huey LY; Janowsky DS
    J Clin Psychiatry; 1979 Feb; 40(2):58-69. PubMed ID: 581671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excretion of doxepin and N-desmethyldoxepin in human milk.
    Kemp J; Ilett KF; Booth J; Hackett LP
    Br J Clin Pharmacol; 1985 Nov; 20(5):497-9. PubMed ID: 4074620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the problems of switching from intravenous to oral administration in drug treatment of endogenous depression--a placebo-controlled double-blind trial with doxepin.
    Adler L; Hajak G; Lehmann K; Kunert HJ; Hoffmann G; Issinger J; Böke J; Huether G; Rüther E
    Pharmacopsychiatry; 1997 Mar; 30(2):62-9. PubMed ID: 9131726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxepin and nordoxepin concentrations in body fluids and tissues in doxepin associated deaths.
    Gronewold A; Dettling A; Haffner HT; Skopp G
    Forensic Sci Int; 2009 Sep; 190(1-3):74-9. PubMed ID: 19524381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intoxication with a tricyclic antidepressant].
    Sakka SG; Kuethe F; Demme U; Hüttemann E
    Anaesthesist; 2007 Jun; 56(6):581-6. PubMed ID: 17464486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxepin plasma levels and anxiolytic response.
    Norman TR; Burrows GD; Bianchi GN; Maguire KP; Wurm JM
    Int Pharmacopsychiatry; 1980; 15(4):247-52. PubMed ID: 7021450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative determination of doxepin and desmethyldoxepin in rat plasma by means of gas-liquid chromatography-mass fragmentography.
    Frigerio A; Pantarotto C; Franco R; Gomeni R; Morselli PL
    J Chromatogr; 1977 Jan; 130():354-60. PubMed ID: 853083
    [No Abstract]   [Full Text] [Related]  

  • 40. Cis- and trans-isomers of doxepin and desmethyldoxepin in the plasma of depressed patients treated with doxepin.
    Hrdina PD; Bakish D; Swenson S; Lapierre YD
    Ther Drug Monit; 1990 Mar; 12(2):129-33. PubMed ID: 2315969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.